Zdrowie i gospodarka · 03/09/2008

FDA Releases Draft Guidance on M3(R2) Nonclinical Safety Studies for Pharmaceuticals

The FDA has made available a draft guidance document, M3(R2), which outlines the requirements for nonclinical safety studies needed for human clinical trials and marketing authorization of pharmaceuticals, aiming to streamline the process and reduce animal testing.